Infant, Child, and Maternal Probiotic Supplements Market Research Report and Outlook by 2028

The market for probiotic supplements aimed at infants, children, and mothers is anticipated to grow significantly, reaching an estimated US$ 1,081.70 million by 2028, up from US$ 604.94 million in 2021. This growth represents a compound annual growth rate (CAGR) of 8.7% from 2022 to 2028.

Probiotics are defined as live microorganisms that contribute positively to digestive health and enhance the overall condition of the human gut. They are essential in preventive healthcare, as they help avert diseases by bolstering the immune system. The focus on gut health has emerged as a primary concern for many consumers, leading to a heightened awareness of the advantages of probiotics. This awareness has significantly increased the demand for probiotic supplements tailored for infants, children, and pregnant women. Additionally, the rising incidence of digestive issues among children, often linked to poor dietary habits, presents a substantial opportunity for growth in the infant, child, and maternal probiotic supplements sector.

The market is categorized by end use into three segments: infants and toddlers, children, and maternal women. In 2020, the children segment held the largest share of the market. However, the maternal women segment is projected to experience the highest growth rate during the forecast period.

Probiotic supplements are increasingly favored by pregnant women due to their potential benefits, which include reducing the risk of eczema in newborns, minimizing childbirth complications, and enhancing the metabolic health of mothers-to-be. Pregnancy induces significant physiological and immune system changes, including shifts in the gut microbiome. Probiotic supplements can effectively address these changes, aiding in weight management for expectant mothers.

Geographically, the market for infant, child, and maternal probiotic supplements is divided into North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW). North America dominated the market in 2020, while the Asia Pacific region is projected to exhibit the fastest growth rate during the forecast period. The leading position of North America can be attributed to the growing consumer awareness regarding the benefits of probiotics for infants, children, and pregnant women. Parents in this region are particularly focused on the health and development of their children.

Common health issues prevalent in North America include allergies, asthma, urinary tract infections, colic in infants, and autism. According to the Allergy & Asthma Foundation, around 5.2 thousand children in the United States were diagnosed with seasonal allergic rhinitis in 2018. The increasing health concerns among children have prompted parents to seek out probiotic supplements, contributing to market growth.

Furthermore, North American governments are implementing initiatives aimed at enhancing the health of infants and children. One such initiative is Healthy Start, which focuses on reducing infant mortality rates and improving prenatal health. This has led to an increased use of probiotic supplements during both prenatal and postnatal periods, further propelling the growth of the market in North America.

Key players in the infant, child, and maternal probiotic supplements market include Bayer Corporation, Nestle S.A., Mommy's Bliss Inc., LoveBug Probiotics, BioGaia AB, MaryRuth Organics, LLC, Pharmavite LLC, Evolve Biosystems, Biomeology, and Nordic Naturals. These companies are actively engaged in launching new products and expanding their geographical reach to cater to the growing global demand.

The overall size of the infant, child, and maternal probiotic supplements market has been determined through a combination of primary and secondary research methods. The research process began with extensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data related to the market. Additionally, numerous primary interviews were conducted with industry stakeholders to validate the findings and gain deeper analytical insights. Participants in this research included industry experts such as vice presidents, business development managers, market intelligence managers, national sales managers, and external consultants, including valuation experts, research analysts, and key opinion leaders specializing in the infant, child, and maternal probiotic supplements market.